Lam Research Corporation $LRCX Shares Acquired by Solstein Capital LLC

Solstein Capital LLC lifted its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 742.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 590 shares of the semiconductor company’s stock after purchasing an additional 520 shares during the quarter. Solstein Capital LLC’s holdings in Lam Research were worth $57,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Envestnet Asset Management Inc. grew its stake in shares of Lam Research by 12.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 3,495,415 shares of the semiconductor company’s stock worth $340,244,000 after purchasing an additional 378,090 shares during the period. Nisa Investment Advisors LLC grew its stake in shares of Lam Research by 28.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 537,348 shares of the semiconductor company’s stock worth $52,428,000 after purchasing an additional 120,328 shares during the period. Oppenheimer Asset Management Inc. grew its stake in shares of Lam Research by 528.7% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 23,123 shares of the semiconductor company’s stock worth $2,251,000 after purchasing an additional 19,445 shares during the period. Prudent Man Advisors LLC grew its stake in shares of Lam Research by 20.3% during the 2nd quarter. Prudent Man Advisors LLC now owns 17,752 shares of the semiconductor company’s stock worth $1,728,000 after purchasing an additional 2,993 shares during the period. Finally, Optimum Investment Advisors grew its stake in Lam Research by 4.9% in the 2nd quarter. Optimum Investment Advisors now owns 9,700 shares of the semiconductor company’s stock valued at $944,000 after acquiring an additional 450 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on LRCX shares. Citigroup increased their price objective on shares of Lam Research from $120.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Stifel Nicolaus set a $160.00 price objective on shares of Lam Research and gave the company a “buy” rating in a research note on Thursday. Wells Fargo & Company increased their price objective on shares of Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research note on Thursday, October 23rd. HSBC set a $127.00 price objective on shares of Lam Research and gave the company a “hold” rating in a research note on Tuesday, September 30th. Finally, Raymond James Financial increased their price objective on shares of Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $148.83.

Insider Buying and Selling at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This represents a 17.21% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.31% of the stock is currently owned by insiders.

Lam Research Price Performance

Lam Research stock opened at $156.90 on Tuesday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $158.25. The stock has a market capitalization of $197.86 billion, a P/E ratio of 34.56, a P/E/G ratio of 1.66 and a beta of 1.84. The firm’s 50-day moving average is $124.39 and its two-hundred day moving average is $100.67. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same period last year, the company earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 24th. This is an increase from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s payout ratio is currently 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.